S&P 500
7,663.43
-93.74
-1.21%
Dow
52,867.98
+11.89
+0.02%
Nasdaq
26,008.86
-694.00
-2.60%
NYSE Composite
24,275.53
+22.41
+0.09%
Russell 2000
2,784.03
+3.01
+0.11%
VIX
19.03
+2.35
+14.09%
IMDX · Insight Molecular Diagnostics Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Insight Molecular Diagnostics Inc (IMDX)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$2.85
-0.18
(-5.94%)
● At close: October 22 at 4:00:00 PM EDT
DAY'S RANGE
$2.85
$2.76
$2.97
52-WEEK RANGE
$2.85
$2.42
$8.51
What's happening
- IMDX is down 5.94% today, trading at $2.85. — Live quote
- Volume today (11,198) is well below its 3-month average of 240,140. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 13 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.31 actual vs. $-0.25 estimated (-24.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 6
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
IMDX
-59.73%
vs S&P 500
-73.10%
1-YEAR RETURN
IMDX
-54.45%
vs S&P 500
-69.61%
6-MONTH RETURN
IMDX
-21.35%
3-MONTH RETURN
IMDX
-39.48%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.31
Est. $-0.25
MISS -24.4%
2026-04-26 (Q1 2026)
$-0.12
Est. $-0.27
BEAT +55.0%
2026-01-26 (Q4 2025)
$-0.72
Est. $-0.24
MISS -197.5%
2025-10-26 (Q3 2025)
$-0.34
Est. $-0.21
MISS -59.0%
Valuation Measures & Ratios
Enterprise Value4$74.3M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)54.67
Price / Book7787.10
EV4 / Revenue44.50
EV4 / EBITDA—
Profit Margin-2955.63%
Operating Margin-3011.86%
Return on Equity (ROE8)-426.68%
Return on Assets (ROA9)-141.47%
Avg Volume (3M)240,140
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $212.1M | $117.3M | $106.0M | $97.4M | $78.8M |
| P/E | -5.87 | -3.72 | -2.60 | -2.83 | -2.33 |
| Price/Sales | 202.22 | 39.78 | 34.97 | 33.89 | 31.10 |
| Price/Book | -9.96 | -10.97 | -11.53 | 88.72 | 7.71 |
| EV/Revenue | 185.29 | 30.21 | 28.80 | 25.44 | 18.85 |
| EV/EBITDA | -5.67 | -2.98 | -2.23 | — | — |
| ROE | 169.71% | 295.17% | 443.24% | -3136.25% | -331.01% |
| ROA | -122.77% | -78.06% | -92.77% | -68.17% | -56.04% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short973,029
Change from Prior Settlement-1.96%
% of Float—
Days to Cover (Short Ratio)2.91
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-09-21; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -53.9% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -2955.6%. Finnhub fundamentals ↗
- Trailing 52-week price return is -54.4%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on IMDX
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $239.0K | $32.0K | $260.0K | $518.0K | $2.1M | $115.0K | $104.0K | $176.0K |
| Gross profit | $157.0K | $15.0K | $139.0K | $338.0K | $1.3M | $50.0K | $50.0K | $45.0K |
| Operating income | -$11.4M | -$4.4M | -$11.0M | -$9.8M | -$6.8M | -$13.5M | -$4.6M | -$9.3M |
| Net income | -$11.3M | -$4.3M | -$10.9M | -$9.7M | -$6.7M | -$13.5M | -$4.5M | -$9.1M |
| EPS (diluted) | $-0.31 | $-0.12 | $-0.34 | $-0.30 | $-0.26 | $-0.98 | $-0.36 | $-1.13 |
| EPS (basic) | $-0.31 | $-0.12 | $-0.34 | $-0.30 | $-0.26 | $-0.98 | $-0.36 | $-1.13 |
| Operating margin | -$4.8K | -$13.8K | -$4.2K | -$1.9K | -$318 | -$11.8K | -$4.5K | -$5.3K |
| Net margin | -$4.7K | -$13.4K | -$4.2K | -$1.9K | -$312 | -$11.7K | -$4.4K | -$5.2K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $29.4M | $40.4M | $25.8M | $43.9M | $50.5M | $60.4M | $35.1M | $70.2M |
| Total liabilities | $50.7M | $51.1M | $57.2M | $53.1M | $49.4M | $50.1M | $47.4M | $60.5M |
| Stockholders' equity | -$21.3M | -$10.7M | -$31.5M | -$9.2M | $1.1M | $10.2M | -$12.3M | $9.7M |
| Total current assets | $20.5M | $30.5M | $15.3M | $21.4M | $26.8M | $36.3M | $11.8M | $4.8M |
| Total current liabilities | $10.3M | $12.0M | $12.1M | $7.7M | $6.7M | $9.7M | $7.3M | $9.1M |
| Cash & equivalents | $17.8M | $28.2M | $11.6M | $18.7M | $24.3M | $31.0M | $8.6M | $3.4M |
| Accounts receivable | $192.0K | $157.0K | $1.1M | $258.0K | $512.0K | $3.5M | $1.6M | $209.0K |
| Inventory | $207.0K | $382.0K | $446.0K | $471.0K | $693.0K | $459.0K | $410.0K | $232.0K |
| Other current assets | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $6.0M | $8.9M | $6.4M | $5.8M | $6.4M | $6.8M | $6.3M | $6.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible assets | — | — | $0 | $14.6M | $14.6M | $14.6M | $14.6M | $56.5M |
| Other non-current assets | $556.0K | $574.0K | $593.0K | $672.0K | $702.0K | $642.0K | $691.0K | $699.0K |
| Accounts payable | $1.9M | $1.6M | $2.5M | $1.1M | $1.3M | $2.3M | $1.6M | $872.0K |
| Accrued liabilities | $1.9M | $3.3M | $2.5M | $2.2M | $1.5M | $2.5M | $1.9M | $1.9M |
| Other current liabilities | $2.0M | $2.7M | $2.8M | — | — | — | $638.0K | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $394.9M | $394.3M | $369.2M | $368.5M | $368.0M | $367.4M | $338.2M | $326.7M |
| Retained earnings | -$416.3M | -$405.1M | -$400.8M | -$377.8M | -$367.0M | -$357.2M | -$350.5M | -$317.0M |
| Accumulated other comprehensive income (loss) | $67.0K | $71.0K | $86.0K | $86.0K | $85.0K | $41.0K | $21.0K | $57.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.3M | -$7.6M | -$5.5M | -$4.6M | -$6.2M | -$5.8M | -$5.4M | -$5.5M |
| Investing cash flow | -$779.0K | -$613.0K | -$1.5M | -$1.1M | -$349.0K | -$307.0K | -$210.0K | -$87.0K |
| Financing cash flow | -$564.0K | $24.7M | -$252.0K | -$120.0K | -$114.0K | $28.6M | $10.8M | -$255.0K |
| Free cash flow | -$10.0M | -$8.3M | -$7.0M | -$5.7M | -$6.5M | -$6.1M | -$5.6M | -$5.6M |
| Capital expenditures | $779.0K | $613.0K | $1.5M | $1.1M | $349.0K | $307.0K | $214.0K | $87.0K |
| Depreciation & amortization | $665.0K | $631.0K | $1.7M | $584.0K | $559.0K | $491.0K | $1.2M | $340.0K |
| Share-based compensation | $661.0K | $615.0K | $721.0K | $521.0K | $504.0K | $473.0K | $499.0K | $450.0K |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | $35.0K | -$971.0K | $870.0K | -$254.0K | -$3.0M | $1.9M | $1.4M | $124.0K |
| Change in inventory | -$175.0K | -$64.0K | -$25.0K | -$222.0K | $234.0K | $49.0K | $178.0K | $232.0K |
| Debt issued | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $237.0K | — | $72.0K | — | $0 | — | $0 | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $4.1M | $1.9M | $1.5M | $958.0K | $2.2M |
| Gross profit | $2.3M | $740.0K | $413.0K | -$18.0K | $1.4M |
| Operating income | -$51.1M | -$61.0M | -$25.1M | -$18.0M | -$53.7M |
| Net income | -$50.2M | -$60.7M | -$27.8M | -$72.9M | -$64.1M |
| EPS (diluted) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | — |
| EPS (basic) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | $-0.72 |
| Operating margin | -$1.3K | -$3.2K | -$1.7K | -$1.9K | -$2.4K |
| Net margin | -$1.2K | -$3.2K | -$1.8K | -$7.6K | -$2.9K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Jan '23 | Dec '22 |
|---|---|---|---|---|---|
| Total assets | $25.8M | $35.1M | $74.9M | — | $100.1M |
| Total liabilities | $57.2M | $47.4M | $49.3M | — | $60.5M |
| Stockholders' equity | -$31.5M | -$12.3M | $20.5M | — | $34.3M |
| Total current assets | $15.3M | $11.8M | $10.7M | — | $25.5M |
| Total current liabilities | $12.1M | $7.3M | $7.2M | — | $12.1M |
| Cash & equivalents | $11.6M | $8.6M | $9.4M | — | $20.0M |
| Accounts receivable | $1.1M | $1.6M | $484.0K | — | $2.0M |
| Inventory | $446.0K | $410.0K | — | — | — |
| Other current assets | — | — | — | — | — |
| Property, plant & equipment | $9.2M | $6.3M | $4.7M | — | $8.7M |
| Goodwill | — | — | — | — | — |
| Intangible assets | $0 | $14.6M | $56.6M | — | $61.6M |
| Other non-current assets | $593.0K | $691.0K | $463.0K | — | $371.0K |
| Accounts payable | $2.5M | $1.6M | $953.0K | — | $1.3M |
| Accrued liabilities | $2.5M | $1.9M | $1.6M | — | $1.8M |
| Other current liabilities | $2.8M | $638.0K | — | — | — |
| Long-term debt | — | — | — | — | — |
| Common stock & paid-in capital | $369.2M | $338.2M | $310.3M | — | $294.9M |
| Retained earnings | -$400.8M | -$350.5M | -$289.9M | $1.4M | -$260.7M |
| Accumulated other comprehensive income (loss) | $86.0K | $21.0K | $49.0K | — | $39.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$22.2M | -$20.7M | -$23.3M | -$45.6M | -$35.9M |
| Investing cash flow | -$3.2M | -$512.0K | -$932.0K | -$4.3M | -$14.0M |
| Financing cash flow | $28.1M | $20.4M | $12.2M | $35.8M | $78.4M |
| Free cash flow | -$25.4M | -$21.2M | -$23.6M | -$49.9M | -$38.2M |
| Capital expenditures | $3.2M | $516.0K | $281.0K | $4.3M | $2.2M |
| Depreciation & amortization | $2.2M | $1.6M | $1.7M | — | — |
| Share-based compensation | $2.2M | $1.8M | $2.8M | $10.0M | $6.8M |
| Deferred income taxes | — | — | $0 | $0 | -$9.3M |
| Change in accounts receivable | -$485.0K | $1.1M | -$109.0K | $575.0K | $1.2M |
| Change in inventory | $36.0K | $410.0K | — | — | — |
| Debt issued | — | — | — | — | — |
| Tax withholding on stock comp | $72.0K | $0 | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding IMDX as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-02-06 to 2026-07-01
Recent transactions
- Insiders have net bought 289,803 shares over the last 182 days, across 4 purchases and 0 sales.
- Most recent: SILVERMAN LOU (Director) — Tax withholding of 7,700 shares on 2026-07-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)289,803 sh(4 txns)
Sales (open market)0 sh(0 txns)
Net Shares+289,803
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| SILVERMAN LOU | Director | Tax withholding | 2026-07-01 | 7,700 |
| Last Andrew J. | Director | Tax withholding | 2026-07-01 | 7,700 |
| Arno Andrew | Director | Tax withholding | 2026-07-01 | 12,100 |
| BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 2026-04-27 | 250,923 |
| James Andrea S. | Chief Financial Officer | Option exercise | 2026-03-26 | 28,302 |
| Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Option exercise | 2026-03-26 | 6,289 |
| Riggs Josh | CEO and President | Option exercise | 2026-03-26 | 47,170 |
| SMITH PATRICK W | 10% owner | Open market purchase | 2025-02-07 | 1,077,600 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-01 | SILVERMAN LOU | Director | Tax withholding | 7,700 | $5.69 |
| 2026-07-01 | Last Andrew J. | Director | Tax withholding | 7,700 | $5.69 |
| 2026-07-01 | Arno Andrew | Director | Tax withholding | 12,100 | $5.69 |
| 2026-06-11 | SILVERMAN LOU | Director | Grant / award | 26,943 | $0.00 |
| 2026-06-11 | Last Andrew J. | Director | Grant / award | 26,943 | $0.00 |
| 2026-06-11 | Arno Andrew | Director | Grant / award | 32,331 | $0.00 |
| 2026-04-27 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 250,923 | $3.64 |
| 2026-04-27 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
| 2026-04-24 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 38,880 | $3.53 |
| 2026-04-24 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
| 2026-04-23 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 280,381 | $3.50 |
| 2026-04-23 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
| 2026-04-20 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 40,690 | $3.88 |
| 2026-04-20 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
| 2026-04-17 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 40,114 | $3.57 |
| 2026-04-17 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
| 2026-04-16 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 102,057 | $3.45 |
| 2026-04-16 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
| 2026-03-26 | James Andrea S. | Chief Financial Officer | Option exercise | 28,302 | — |
| 2026-03-26 | James Andrea S. | Chief Financial Officer | Tax withholding | 11,298 | $4.11 |
| 2026-03-26 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Option exercise | 6,289 | — |
| 2026-03-26 | Liu James Yang | VP ACCT, Cntlr, Treasurer, PAO | Tax withholding | 2,578 | $4.11 |
| 2026-03-26 | Riggs Josh | CEO and President | Option exercise | 47,170 | — |
| 2026-03-26 | Riggs Josh | CEO and President | Tax withholding | 12,310 | $4.11 |
| 2026-02-10 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 521,739 | $5.75 |
| 2026-02-10 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
| 2025-10-31 | James Andrea S. | Chief Financial Officer | Option exercise | 50,000 | $0.00 |
| 2025-07-01 | SILVERMAN LOU | Director | Grant / award | 35,000 | $0.00 |
| 2025-07-01 | Arno Andrew | Director | Grant / award | 55,000 | $0.00 |
| 2025-07-01 | Last Andrew J. | Director | Grant / award | 35,000 | $0.00 |
| 2025-02-07 | James Andrea S. | Chief Financial Officer | Open market purchase | 97,561 | $2.05 |
| 2025-02-07 | SMITH PATRICK W | 10% owner | Open market purchase | 1,077,600 | $2.05 |
| 2025-02-07 | SMITH PATRICK W | 10% owner | Other acquisition/disposition | 385,814 | $2.05 |
| 2025-02-06 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 660,207 | $2.05 |
| 2025-02-06 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
| 2025-02-06 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 4,505,488 | $2.05 |
| 2025-02-06 | BROADWOOD PARTNERS, L.P. | 10% owner | Open market purchase | 0 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-23 02:57 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-21 | 8-K | 2026-09-15 | View on SEC.gov → |
| 2026-08-10 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-07-06 | 4 | 2026-07-01 | View on SEC.gov → |
| 2026-06-17 | 8-K | 2026-06-11 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-11 | View on SEC.gov → |
| 2026-05-13 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-13 | 8-K | 2026-05-13 | View on SEC.gov → |
Recent news
Headlines about IMDX (Insight Molecular Diagnostics Inc.). Links open the publisher — we don’t host full articles.
-
BLK,MAT,EHC,PII,HCA,SPGI,SITM,IMDX,NBHC | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
Yahoo · 2026-10-14 -
iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings
Yahoo · 2026-10-12 -
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
Yahoo Finance · 2026-09-02 -
Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-17 -
Insight Molecular Diagnostics Inc. (IMDX) Discusses Advances in Heart Transplant Rejection Testing and Evolution of Diagnostic Methods Transcript
Seeking Alpha · 2026-08-17 -
Oncocyte Eyes Faster, Less Invasive Heart Transplant Rejection Testing
Yahoo Finance · 2026-08-17 -
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
Yahoo Finance · 2026-08-11
No headlines in this category right now — try “All”.